The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Industry News
KV Pharma Sues Former CEO (First Chief to be Barred From Industry)
Marc Hermelin is the first drug company executive to be banned from participating in federal health care programs by the Department of Health and Human Services.
Oct. 19, 2011
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
‘Cobots’ drive pharma’s shift toward scalable cell therapies
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Trending
Biopharma’s manufacturing agility wanes amid supply chain resilience: survey
CDMOs in China and US are forecast to see fastest growth: analysis
Lonza confirms full-year 2025 outlook for CDMO business amid geopolitical uncertainty
Sponsored Picks
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
Attindas Hygienic Partners Avoids Catastrophic Failure with Remote Lubrication
Sponsored
AI-Powered QMS: The Future of Quality Management
Load More Content